Type I glycogen storage disease: Nine years of management with cornstarch
Authors:
- 1 January 1993
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 152 (S1) , 56-59
Abstract
Long-term effects of cornstarch (CS) therapy on biochemical values and physical growth in children with type I glycogen storage disease (GSD I) were compared to those of children receiving continuous nocturnal nasogastric glucose feedings (CNG). Only patients who had received more than 5 years of dietary therapy (either CS or CNG) were evaluated. Six patients (five female, age 13.5 years±1.3, range 11.7–16.5 years) received CS (1.75–2.5 g/kg, four times daily) and seven patients (five female, age 9.6±2.5 years, range 7.3–14.8 years) received CNG. Blood glucose, lactate, cholesterol and triglyceride levels were not significantly different between the two methods of treatment. All patients maintained linear growth rates normal for their age. The standard deviation score of height after 6.7±1.6 years (range 5–9 years) of CS treatment was −1.29±0.59 and after 8.8±2.4 years (range 7–14 years) of CNG was −1.24±0.63. These values did not differ significantly from each other or from the target height, an estimate of genetic potential for height as determined from parental heights. With the exceptions of diarrhea, increased flatulence and excess weight gain, there were no adverse effects of CS after 9 years of treatment. Our data suggests that cornstarch is a simple, effective and safe therapy for GSD I.Keywords
This publication has 16 references indexed in Scilit:
- Glucose therapy for glycogenosis type 1 in infants: Comparison of intermittent uncooked cornstarch and continuous overnight glucose feedingsThe Journal of Pediatrics, 1990
- Glycogen Storage Disease Type I and III and Pyruvate Carboxylase Deficiency: Results of Long‐Term Treatment with Uncooked CornstarchActa Paediatrica, 1988
- Phytate in Foods1987
- Long‐term cornstarch therapy in glycogen storage disease types I, Ib and IIIJournal of Inherited Metabolic Disease, 1986
- Management of postoperative nesidioblastosis with zinc protamine glucagon and oral starchThe Journal of Pediatrics, 1986
- The Dietary Treatment of Children with Type I Glycogen Storage Disease with Slow Release CarbohydratePediatric Research, 1984
- Cornstarch Therapy in Type I Glycogen-Storage DiseaseNew England Journal of Medicine, 1984
- Effects of Changes in Cell Size and Ouabain Sensitive Respiration on Development of Brown Adipose Tissue Thermogenesis in the RabbitPediatric Research, 1983
- Continuous Nocturnal Intragastric Feeding for Management of Type 1 Glycogen-Storage DiseaseNew England Journal of Medicine, 1976
- Standards for Children's Height at Ages 2-9 Years Allowing for Height of ParentsArchives of Disease in Childhood, 1970